Fidaxomicin 200 mg/1 (Fidaxomicin TABLET, FILM COATED) 200 mg/1

Fidaxomicin works by inhibiting bacterial DNA-dependent RNA polymerase, which suppresses protein synthesis and leads to the death of bacterial cells. This mechanism is particularly effective against Clostridioides difficile, making it a targeted treatment for infections caused by this bacterium.

The usual dose of Fidaxomicin is determined by a healthcare provider based on the patient's condition. It is typically administered as one 200 mg tablet orally twice daily for 10 days. Always follow the prescribed dosage and consult your healthcare provider for personalized advice.

The safety of Fidaxomicin during pregnancy and breastfeeding is unknown. It is important to consult a healthcare provider before using Fidaxomicin if you are pregnant, planning to become pregnant, or breastfeeding, to weigh the potential benefits and risks.

To order Fidaxomicin from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then provide pricing, availability, shipping, and the necessary import paperwork.

Fidaxomicin is a targeted treatment for Clostridioides difficile infection, offering a different mechanism of action compared to other antibiotics like vancomycin. It is particularly effective in reducing the recurrence of infections, making it a preferred choice in certain clinical scenarios.

Fidaxomicin should be stored below 25°C, kept in the original pack, and protected from moisture. Ensure that the medication is stored in a cool, dry place away from direct sunlight and out of reach of children. Always follow the storage instructions provided on the packaging.

Fidaxomicin is administered orally as a film-coated tablet. It can be taken with or without food. The typical dosage is one 200 mg tablet taken twice daily for 10 days, as prescribed by a healthcare provider. Always follow the administration instructions provided by your healthcare professional.

The most serious risks associated with Fidaxomicin include the recurrence of Clostridioides difficile infection, treatment failure, and in rare cases, death. It is important to monitor for signs of persistent or worsening symptoms and to consult a healthcare provider if any severe side effects occur.

Fidaxomicin should not be used by individuals who are allergic to fidaxomicin or any of its components. It should be used with caution in patients with kidney or liver problems. Always consult a healthcare provider to determine if Fidaxomicin is suitable for you, especially if you have pre-existing medical conditions or are taking other medications.